Li H, Seitz P K, Selvanayagam P, Rajaraman S, Cooper C W
Department of Pharmacology and Toxicology, University of Texas Medical Branch, 77555, Galveston, TX.
Endocrine. 1996 Dec;5(3):323-30. doi: 10.1007/BF02739066.
Previously, using human hepatoma cells (HepG2), we found that immunoneutralization of secreted PTHrP increased cell growth. Here we asked whether PTHrP production was affected by agents that alter growth of Hep G2 cells. Immunoreactive PTHrP in medium and PTHrP mRNA expression were examined. Treatment of cells with 10 μM hydrocortisone or 1 ng/mL TGF-β1 for 72 h inhibited cell growth by 28±6 and 36±2% and increased PTHrP in medium by 128±10 and 525 ±27%, respectively. The increase in PTHrP produced by both agents was dose-and time-dependent, and the increased PTHrP was accompanied by dose-and time-dependent enhanced expression of PTHrP mRNA. In contrast, 10% fetal bovine serum (FBS) for 72 h increased cell growth by 38±6% (vs serum-free medium) and decreased PTHrP production by 49±4% whereas culture in high glucose (3-4g/L) increased cell growth by 43±1% (vs 1 g/L glucose) and decreased PTHrP by 55±0.4%. Inhibition of PTHrP by both FBS and glucose was dose-dependent; FBS also inhibited PTHrP mRNA. The results show that increased cell growth was associated with decreased PTHrP production, while decreased growth was accompanied by increased PTHrP production. The findings imply that PTHrP may help mediate growth effects of these agents on Hep G2 cells.
此前,我们利用人肝癌细胞(HepG2)发现,分泌型甲状旁腺激素相关蛋白(PTHrP)的免疫中和作用可促进细胞生长。在此,我们探讨了改变Hep G2细胞生长的因素是否会影响PTHrP的产生。检测了培养基中免疫反应性PTHrP及PTHrP mRNA的表达。用10 μM氢化可的松或1 ng/mL转化生长因子-β1(TGF-β1)处理细胞72小时,细胞生长分别受到28±6%和36±2%的抑制,培养基中PTHrP分别增加128±10%和525±27%。两种药物引起的PTHrP增加均呈剂量和时间依赖性,且PTHrP增加伴随着PTHrP mRNA表达的剂量和时间依赖性增强。相比之下,10%胎牛血清(FBS)处理72小时使细胞生长增加38±6%(与无血清培养基相比),PTHrP产生减少49±4%;而在高糖(3 - 4g/L)培养基中培养使细胞生长增加43±1%(与1g/L葡萄糖相比),PTHrP减少55±0.4%。FBS和葡萄糖对PTHrP的抑制均呈剂量依赖性;FBS还抑制PTHrP mRNA。结果表明,细胞生长增加与PTHrP产生减少相关,而生长减少则伴随着PTHrP产生增加。这些发现提示,PTHrP可能有助于介导这些因素对Hep G2细胞的生长效应。